Journal
MEDIATORS OF INFLAMMATION
Volume 2010, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2010/652098
Keywords
-
Categories
Funding
- Burroughs-Wellcome Career Award in Biomedical Sciences [992840.01]
- Canadian Institutes for Health Research (CIHR)
- Canada Foundation for Innovation [4453]
- Vancouver Coastal Health Research Institute
- Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada/CIHR
Ask authors/readers for more resources
Background. Bacterial flagellin triggers inflammation in mammalian cells via Toll-like receptor (TLR) 5. Release of the chemokine IL-8 in response to flagellin involves NF-kappa B, p38 MAP kinase, and phosphatidylinositol 3-kinase (PI3K). However, PI3K has been reported to be either pro-or anti-inflammatory in different model systems. We hypothesized that this could be due to different activities of the p110 alpha and beta isoforms of PI3K. Results. PI3K and Akt were rapidly activated in Caco-2 colon carcinoma cells by flagellin. Using a plasmid-based shRNA delivery system and novel p110 isoform-specific inhibitors, we found that flagellin-induced IL-8 production was dependent on both p110 alpha and p110 beta. However in the mouse, inhibition of p110 beta but not p110 alpha reduced the increase of serum IL-6 levels induced by intraperitoneal injection of flagellin. Conclusions. These data demonstrate that the p110a and beta isoforms of class IA PI3K are both required for the proinflammatory response to flagellin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available